Anocca Gets Approval for First In-Human Trial in Pancreatic Cancer
March 17, 2025
CTA approval marks Anocca’s transition to a clinical-stage company Anocca AB, a leading T-cell immunotherapy company, announces the authorisation of its Clinical Trial Application (CTA)